+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Diabetes Management Devices Market 2021-2025

  • PDF Icon

    Report

  • 120 Pages
  • May 2021
  • Region: Global
  • TechNavio
  • ID: 5351685
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The publisher has been monitoring the diabetes management devices market and it is poised to grow by USD 14.31 billion during 2021-2025, progressing at a CAGR of over 8% during the forecast period. The report on the diabetes management devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the rising global burden of diabetes and favorable government initiatives. In addition, the rising global burden of diabetes is anticipated to boost the growth of the market as well.

The diabetes management devices market analysis includes the product segmentation and geographic landscape.

The diabetes management devices market is segmented as below:

By Product
  • Blood glucose monitoring devices
  • Insulin delivery systems

By Geography
  • North America
  • Europe
  • Asia
  • ROW

This study identifies the growing demand for advanced insulin delivery devices as one of the prime reasons driving the diabetes management devices market growth during the next few years.

The report on diabetes management devices market covers the following areas:
  • Diabetes management devices market sizing
  • Diabetes management devices market forecast
  • Diabetes management devices market industry analysis

The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading diabetes management devices market vendors that include Abbott Laboratories, B. Braun Melsungen AG, Bionime Corp., Dexcom Inc., Eli Lilly and Co., F. Hoffmann-La Roche Ltd., LifeScan IP Holdings LLC, Medtronic Plc, Novo Nordisk AS, and PHC Holdings Corp. Also, the diabetes management devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

Executive Summary
  • Market Overview

Market Landscape
  • Market ecosystem
  • Value chain analysis

Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2020
  • Market outlook: Forecast for 2020 - 2025

Five Forces Analysis
  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Product
  • Market segments
  • Comparison by Product
  • Blood glucose monitoring devices - Market size and forecast 2020-2025
  • Insulin delivery systems - Market size and forecast 2020-2025
  • Market opportunity by Product

Market Segmentation by End-user
  • Market segments

Customer landscape
  • Customer landscape

Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2020-2025
  • Europe - Market size and forecast 2020-2025
  • Asia - Market size and forecast 2020-2025
  • ROW - Market size and forecast 2020-2025
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape
  • Overview
  • Landscape disruption

Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Bionime Corp.
  • Dexcom Inc.
  • Eli Lilly and Co.
  • F. Hoffmann-La Roche Ltd.
  • LifeScan IP Holdings LLC
  • Medtronic Plc
  • Novo Nordisk AS
  • PHC Holdings Corp.

Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

Exhibits
  • Key Finding 1
  • Key Finding 2
  • Key Finding 3
  • Key Finding 5
  • Key Finding 6
  • Key Finding 7
  • Key Finding 8
  • Parent market
  • Market characteristics
  • Offerings of vendors included in the market definition
  • Market segments
  • Global - Market size and forecast 2020 - 2025 ($ billion)
  • Global market: Year-over-year growth 2020 - 2025 (%)
  • Five forces analysis 2020 & 2025
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition - Five forces 2020
  • Product - Market share 2020-2025 (%)
  • Comparison by Product
  • Blood glucose monitoring devices - Market size and forecast 2020-2025 ($ billion)
  • Blood glucose monitoring devices - Year-over-year growth 2020-2025 (%)
  • Insulin delivery systems - Market size and forecast 2020-2025 ($ billion)
  • Insulin delivery systems - Year-over-year growth 2020-2025 (%)
  • Market opportunity by Product
  • Customer landscape
  • Market share by geography 2020-2025 (%)
  • Geographic comparison
  • North America - Market size and forecast 2020-2025 ($ billion)
  • North America - Year-over-year growth 2020-2025 (%)
  • Europe - Market size and forecast 2020-2025 ($ billion)
  • Europe - Year-over-year growth 2020-2025 (%)
  • Asia - Market size and forecast 2020-2025 ($ billion)
  • Asia - Year-over-year growth 2020-2025 (%)
  • ROW - Market size and forecast 2020-2025 ($ billion)
  • ROW - Year-over-year growth 2020-2025 (%)
  • Key leading countries
  • Market opportunity by geography ($ billion)
  • Impact of drivers and challenges
  • Vendor landscape
  • Landscape disruption
  • Industry risks
  • Vendors covered
  • Market positioning of vendors
  • Abbott Laboratories - Overview
  • Abbott Laboratories - Business segments
  • Abbott Laboratories - Key offerings
  • Abbott Laboratories - Key customers
  • Abbott Laboratories - Segment focus
  • B. Braun Melsungen AG - Overview
  • B. Braun Melsungen AG - Business segments
  • B. Braun Melsungen AG - Key offerings
  • B. Braun Melsungen AG - Key customers
  • B. Braun Melsungen AG - Segment focus
  • Bionime Corp. - Overview
  • Bionime Corp. - Product and service
  • Bionime Corp. - Key offerings
  • Bionime Corp. - Key customers
  • Bionime Corp. - Segment focus
  • Dexcom Inc. - Overview
  • Dexcom Inc. - Business segments
  • Dexcom Inc. - Key offerings
  • Dexcom Inc. - Key customers
  • Dexcom Inc. - Segment focus
  • Eli Lilly and Co. - Overview
  • Eli Lilly and Co. - Business segments
  • Eli Lilly and Co. - Key offerings
  • Eli Lilly and Co. - Key customers
  • Eli Lilly and Co. - Segment focus
  • F. Hoffmann-La Roche Ltd. - Overview
  • F. Hoffmann-La Roche Ltd. - Business segments
  • F. Hoffmann-La Roche Ltd. - Key offerings
  • F. Hoffmann-La Roche Ltd. - Key customers
  • F. Hoffmann-La Roche Ltd. - Segment focus
  • LifeScan IP Holdings LLC - Overview
  • LifeScan IP Holdings LLC - Product and service
  • LifeScan IP Holdings LLC - Key offerings
  • LifeScan IP Holdings LLC - Key customers
  • LifeScan IP Holdings LLC - Segment focus
  • Medtronic Plc - Overview
  • Medtronic Plc - Business segments
  • Medtronic Plc - Key offerings
  • Medtronic Plc - Key customers
  • Medtronic Plc - Segment focus
  • Novo Nordisk AS - Overview
  • Novo Nordisk AS - Business segments
  • Novo Nordisk AS - Key offerings
  • Novo Nordisk AS - Key customers
  • Novo Nordisk AS - Segment focus
  • PHC Holdings Corp. - Overview
  • PHC Holdings Corp. - Business segments
  • PHC Holdings Corp. - Key offerings
  • PHC Holdings Corp. - Key customers
  • PHC Holdings Corp. - Segment focus
  • Currency conversion rates for US$
  • Research Methodology
  • Validation techniques employed for market sizing
  • Information sources
  • List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global diabetes management devices market: Abbott Laboratories, B. Braun Melsungen AG, Bionime Corp., Dexcom Inc., Eli Lilly and Co., F. Hoffmann-La Roche Ltd., LifeScan IP Holdings LLC, Medtronic Plc, Novo Nordisk AS, and PHC Holdings Corp.

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is the growing demand for advanced insulin delivery devices.'

According to the report, one of the major drivers for this market is the rising global burden of diabetes.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Bionime Corp.
  • Dexcom Inc.
  • Eli Lilly and Co.
  • F. Hoffmann-La Roche Ltd.
  • LifeScan IP Holdings LLC
  • Medtronic Plc
  • Novo Nordisk AS
  • PHC Holdings Corp.